Thompson Oncology Group - Knoxville Downtown — Knoxville, Tennessee

Thompson Oncology Group - Knoxville Downtown is a clinical research site located in Knoxville, Tennessee, United States 37916.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Thompson Oncology Group - Knoxville Downtown has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced or Metastatic Unresectable Urothelial Cancer, Carcinoma, Non-Small-Cell Lung.

Sponsors: Gilead Sciences, Takeda.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Knoxville

Browse all research sites in Tennessee · View every site in Knoxville

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thompson Oncology Group - Knoxville Downtown?

Thompson Oncology Group - Knoxville Downtown has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thompson Oncology Group - Knoxville Downtown conducted?

Thompson Oncology Group - Knoxville Downtown has 2 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic Unresectable Urothelial Cancer, Carcinoma, Non-Small-Cell Lung.

Is Thompson Oncology Group - Knoxville Downtown accredited by Crixeo Clinical Trials?

Thompson Oncology Group - Knoxville Downtown has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thompson Oncology Group - Knoxville Downtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.